SGLT2 Inhibitors and Ketone Metabolism in Heart Failure

Sodium-glucose cotransporter-2 (SGLT2) inhibitors have emerged as powerful drugs that can be used to treat heart failure (HF) patients, both with preserved and reduced ejection fraction and in the presence or absence of type 2 diabetes. While the mechanisms underlying the salutary effects of SGLT2 i...

Descripción completa

Detalles Bibliográficos
Autores principales: Saucedo-Orozco, Huitzilihuitl, Voorrips, Suzanne N., Yurista, Salva R., de Boer, Rudolf A., Westenbrink, B. Daan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society of Lipidology and Atherosclerosis 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8792821/
https://www.ncbi.nlm.nih.gov/pubmed/35118019
http://dx.doi.org/10.12997/jla.2022.11.1.1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8792821/
https://www.ncbi.nlm.nih.gov/pubmed/35118019
http://dx.doi.org/10.12997/jla.2022.11.1.1

Ejemplares similares